Exosome-Contained APOH Associated With Antiphospholipid Syndrome

Area of Science:

• Immunology
• Vascular Biology
• Reproductive Medicine

Background:

• Antiphospholipid syndrome (APS) is an autoimmune disorder linked to thrombosis and pregnancy issues.
• Exosomes are extracellular vesicles involved in cell signaling, with emerging roles in pregnancy.
• The specific role of exosomes in APS pathogenesis remains largely unexplored.

Purpose of the Study:

• To investigate the role of exosomes in antiphospholipid syndrome (APS).
• To identify specific exosomal components contributing to APS-related pregnancy complications.
• To explore potential therapeutic targets for APS.

Main Methods:

• Exosomes were isolated from plasma of healthy pregnant individuals (NC-exos) and APS patients (APS-exos).
• Mouse pregnancy models and human umbilical vein endothelial cells (HUVECs) were used to assess exosome effects.
• Quantitative proteomics identified differentially expressed proteins in APS-exos, focusing on apolipoprotein H (APOH).

Main Results:

• APS-exos induced APS-like outcomes in a mouse model and inhibited HUVEC function in vitro.
• Proteomic analysis revealed significant differences in protein cargo between APS-exos and NC-exos.
• Apolipoprotein H (APOH)-carrying exosomes (APOH-exos) were identified as key mediators, impacting HUVECs via the ERK pathway.

Conclusions:

• APS-exos and APOH-exos negatively affect vascular development, contributing to pregnancy complications.
• APOH-exos are implicated as significant players in the mechanisms underlying APS.
• This research offers novel insights into APS pathogenesis and suggests potential therapeutic strategies.